Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Express Scripts
Moodys
Mallinckrodt
Medtronic

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Suppliers and packages for biologic ingredient: palivizumab

➤ Subscribe for complete access

« Back to Dashboard

Suppliers and packages for biologic ingredient: palivizumab

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities
Applicant Tradename Biologic Ingredient Dosage BLA NDA/ANDA Supplier Package Code Package
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 BLA MedImmune, LLC 60574-4113-1 1 mL in 1 VIAL, SINGLE-DOSE (60574-4113-1)
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 BLA MedImmune, LLC 60574-4114-1 .5 mL in 1 VIAL, SINGLE-DOSE (60574-4114-1)
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 BLA Swedish Orphan Biovitrum AB (publ) 66658-230-01 .5 mL in 1 VIAL, SINGLE-DOSE (66658-230-01)
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 BLA Swedish Orphan Biovitrum AB (publ) 66658-231-01 1 mL in 1 VIAL, SINGLE-DOSE (66658-231-01)
>Applicant >Tradename >Biologic Ingredient >Dosage >BLA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
AstraZeneca
Moodys
Dow
Harvard Business School